Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 7, 2003, Pages 801-803

  Blich, Miry ^a,b   Fruchter, O ^a   Edelstein, S ^a   Edoute, Y ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Anticoagulation therapy; Diffuse angiodysplasia; Somatostatin therapy

Indexed keywords

ESTROGEN; HEMOGLOBIN; OCTREOTIDE; PROGESTERONE; SOMATOSTATIN; WARFARIN;

AGED; ANEMIA; ANGIODYSPLASIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; COLON; DRUG EFFICACY; FEMALE; HEMICOLECTOMY; HEMOGLOBIN DETERMINATION; HUMAN; MELENA; PRIORITY JOURNAL;

AGED; ANGIODYSPLASIA; ANTICOAGULANTS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HUMANS; OCTREOTIDE; WARFARIN;

EID: 0042671467     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310001969     Document Type: Article

References (18)

1. Williams CN. Angiodysplasia of the gastrointestinal tract. Can J Gastroenterol 1997;11:123.
2. Harford WV. Gastrointestinal angiodysplasia: clinical features. Endoscopy 1988;20:144-8.
3. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
4. Sharma R, Gorbien MJ. Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients. Arch Intern Med 1995;155:807-12.
5. Blair SL. Small intestinal bleeding. Gastroenterol Clin North Am 1994;23:67-91.
6. Di Girolamo G, Malavasi A, Cassisa L. Chronic bleeding caused by small bowel angiodysplasia: a problem of recognition and diagnosis. Ital J Gastroenterol 1992;24:468-9.
7. Gilmore PR. Angiodysplasia of the upper gastroentestinal tract. J Clin Gastroenterol 1988;10:386-94.
8. Park RHR, Russell RI. Watermelon stomach. Br J Surg 1991;78:395-6.
9. Lewis B, Rivera McMurray S, Kornbluth A. Hormonal therapy for chronic bleeding from diffuse small bowel angiodysplasia. The result of controlled trial in 56 patients. Am J Gastroenterol 1990;85:1266.
10. Tarsoli A, Annibale B, Viscardi A. Treatment of bleeding due to diffuse angiodysplasia of the small intestine with somatostatin analogue. Eur J Gastroenterol Hepatol 1991;3:785-7.
11. Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 1993;88:1424-7.
12. Andersen MR, Aaseby J. Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Scand J Gastroenterol 1996;31:1037-9.
13. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36.
14. Bowers M, McNulty O, Mayne E. Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Hematol 2000;108:524-7.
15. Orsi P, Guatti Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4.
16. Lamberts SWJ. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin). Acta Endocrinol 1987;112:41-55.
17. Joasson G, Wiben O, Kollberg B. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 1981;22:126-37.
18. Scarpignato C. Octreotide: from basic science to clinical medicine. Basel: Karger. Prog Basic Clin Pharmacol 1996;10:234-45.